NEXI earnings
NexImmune Inc. (NEXI) earnings releases and earnings dates - real-time wire coverage of every quarterly report.
Recent earnings items
- NexImmune to Announce Third Quarter 2021 Financial Results and Provide Corporate Update on November 12, 2021GAITHERSBURG, Md., Nov. 08, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (NASDAQ:NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced it plans to report third quarter financial results and provide a corporate update on Friday, November 12, 2021, via press release, prior to the market open. The press release will be accessible under the investor section of the NexImmune's website at www.neximmune.com. About NexImmune NexImmune is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the
- NexImmune to Announce Second Quarter 2021 Financial Results and Provide Corporate Update on August 9, 2021GAITHERSBURG, Md., July 27, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (NASDAQ:NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced it plans to report second quarter financial results and provide a corporate update on Monday, August 9, 2021, via press release, after market close. The press release will be accessible under the investor section of the NexImmune's website at www.neximmune.com. About NexImmune NexImmune is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body's